Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- 19 October 2009
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 374 (9701), 1617-1625
- https://doi.org/10.1016/s0140-6736(09)61302-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein–Barr virus infectionLeukemia, 2007
- Relaxing the Rule of Ten Events per Variable in Logistic and Cox RegressionAmerican Journal of Epidemiology, 2006
- Post-Transplant Lymphoproliferative Disorders Occurring After Renal Transplantation in Adults: Report of 230 Cases From the French RegistryAmerican Journal of Transplantation, 2006
- American Gastroenterological Association Institute Medical Position Statement on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel DiseaseGastroenterology, 2006
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisThe New England Journal of Medicine, 2005
- Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacyCritical Reviews in Oncology/Hematology, 2005
- Risk of haematopoietic cancer in patients with inflammatory bowel diseaseGut, 2005
- The SAP and SLAM families in immune responses and X-linked lymphoproliferative diseaseNature Reviews Immunology, 2003
- Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in FranceBlood, 2002
- Effects of mid‐point imputation on the analysis of doubly censored dataStatistics in Medicine, 1992